Cargando…
Development of an Enzyme-Linked Immunosorbent Assay (ELISA) for Accurate and Prompt Coronavirus Disease 2019 (COVID-19) Diagnosis Using the Rational Selection of Serological Biomarkers
Prompt COVID-19 diagnosis is urgently required to support infection control measures. Currently available serological tests for measuring SARS-CoV-2 antibodies use different target antigens, although their sensitivity and specificity presents a challenge. We aimed to develop an “in-house” serologica...
Autores principales: | Lagousi, Theano, Routsias, John, Spoulou, Vana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618656/ https://www.ncbi.nlm.nih.gov/pubmed/34829317 http://dx.doi.org/10.3390/diagnostics11111970 |
Ejemplares similares
-
Novel Protein-Based Pneumococcal Vaccines: Assessing the Use of Distinct Protein Fragments Instead of Full-Length Proteins as Vaccine Antigens
por: Lagousi, Theano, et al.
Publicado: (2019) -
Comparative Characterization of Human Antibody Response Induced by BNT162b2 Vaccination vs. SARS-CoV-2 Wild-Type Infection
por: Lagousi, Theano, et al.
Publicado: (2022) -
Pneumococcal Immunization Strategies for High-Risk Pediatric Populations Worldwide: One Size Does Not Fit All
por: Lagousi, Theano, et al.
Publicado: (2021) -
Protecting the Offspring, the Gift of Maternal Immunization: Current Status and Future Perspectives
por: Lagousi, Theano, et al.
Publicado: (2022) -
A new enzyme-linked immunosorbent assay (ELISA) for human free and bound kallikrein 9
por: Filippou, Panagiota, et al.
Publicado: (2017)